PURPOSE: To describe time trends of cancer in Catalonia, Spain, during the period 1993-2007. METHODS/PATIENTS: Data have been provided by two population-based cancer registries, Girona and Tarragona, and the Catalan mortality registry. Cancer incidence in Catalonia has been estimated through modeling methods using data from these health structures. RESULTS: During 2003-2007, there were 20,042 cancer cases and 9,842 deaths per year among men and 13,673 new cancer cases and 5,882 deaths among women. The most frequent incident cancers among men were prostate (N = 4,258), lung (N = 3,021), colorectal (N = 3,007) and bladder (N = 2,238), whereas among women they were breast (N = 3,907), colorectal (N = 2,088), corpus uteri (N = 734) and lung (N = 527). During 1993-2007, age-standardized incidence rates (ASIRs) rose 1.2 % per year among men [prostate (6.3 %), testis (5.7 %), kidney (2.9 %), liver (2.2 %) and colorectal (2.1 %)]. ASIRs decreased for stomach (-2.9 %), oral cavity and pharynx (-2.8 %), larynx (-2.7 %) and esophagus (-2 %). Among women, ASIRs only rose for lung (5.2 %), kidney (3.1 %), oral cavity and pharynx (2.6 %) and thyroid (1.6 %). ASIRs decreased for corpus uteri (-2.3 %), stomach (-1.7 %) and ovary (-1.6 %). Cancer mortality decreased -1.3 % per year among men and -2.1 % among women during the same period. CONCLUSION: Among men, the decrease of incidence/mortality of tobacco-related tumors was related to a reduction of smoking prevalence. Among women, the stabilization of breast cancer incidence and the rise of lung cancer incidence are similar to that observed in most European regions. These results allow assessing the effectiveness of public health strategies and they pose new frontiers for cancer control in Catalonia.
PURPOSE: To describe time trends of cancer in Catalonia, Spain, during the period 1993-2007. METHODS/PATIENTS: Data have been provided by two population-based cancer registries, Girona and Tarragona, and the Catalan mortality registry. Cancer incidence in Catalonia has been estimated through modeling methods using data from these health structures. RESULTS: During 2003-2007, there were 20,042 cancer cases and 9,842 deaths per year among men and 13,673 new cancer cases and 5,882 deaths among women. The most frequent incident cancers among men were prostate (N = 4,258), lung (N = 3,021), colorectal (N = 3,007) and bladder (N = 2,238), whereas among women they were breast (N = 3,907), colorectal (N = 2,088), corpus uteri (N = 734) and lung (N = 527). During 1993-2007, age-standardized incidence rates (ASIRs) rose 1.2 % per year among men [prostate (6.3 %), testis (5.7 %), kidney (2.9 %), liver (2.2 %) and colorectal (2.1 %)]. ASIRs decreased for stomach (-2.9 %), oral cavity and pharynx (-2.8 %), larynx (-2.7 %) and esophagus (-2 %). Among women, ASIRs only rose for lung (5.2 %), kidney (3.1 %), oral cavity and pharynx (2.6 %) and thyroid (1.6 %). ASIRs decreased for corpus uteri (-2.3 %), stomach (-1.7 %) and ovary (-1.6 %). Cancer mortality decreased -1.3 % per year among men and -2.1 % among women during the same period. CONCLUSION: Among men, the decrease of incidence/mortality of tobacco-related tumors was related to a reduction of smoking prevalence. Among women, the stabilization of breast cancer incidence and the rise of lung cancer incidence are similar to that observed in most European regions. These results allow assessing the effectiveness of public health strategies and they pose new frontiers for cancer control in Catalonia.
Authors: Ramon Clèries; Jose Miguel Martínez; Victor Moreno; Yutaka Yasui; Josepa Ribes; Josep Maria Borràs Journal: Epidemiology Date: 2013-05 Impact factor: 4.822
Authors: J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray Journal: Eur J Cancer Date: 2013-02-26 Impact factor: 9.162
Authors: J Ribes; L Esteban; R Clèries; J Galceran; R Marcos-Gragera; R Gispert; A Ameijide; M L Vilardell; J Borras; A Puigdefabregas; M Buxó; A Freitas; A Izquierdo; J M Borras Journal: Clin Transl Oncol Date: 2013-12-12 Impact factor: 3.405
Authors: R Clèries; A Ameijide; R Marcos-Gragera; L Pareja; M Carulla; M-L Vilardell; L Esteban; M Buxó; J-A Espinàs; A Puigdefàbregas; J Ribes; A Izquierdo; J Galceran; J M Borrás Journal: Clin Transl Oncol Date: 2017-10-12 Impact factor: 3.405
Authors: Marta Trapero-Bertran; Amelia Acera Pérez; Silvia de Sanjosé; Josep Maria Manresa Domínguez; Diego Rodríguez Capriles; Ana Rodriguez Martinez; Josep Maria Bonet Simó; Norman Sanchez Sanchez; Pablo Hidalgo Valls; Mireia Díaz Sanchis Journal: BMC Public Health Date: 2017-02-14 Impact factor: 3.295
Authors: José Antonio Baeyens-Fernández; Elena Molina-Portillo; Marina Pollán; Miguel Rodríguez-Barranco; Rosario Del Moral; Lorenzo Arribas-Mir; Emilio Sánchez-Cantalejo Ramírez; María-José Sánchez Journal: BMC Cancer Date: 2018-08-02 Impact factor: 4.430
Authors: M Mena; J Frias-Gomez; M Taberna; B Quirós; S Marquez; O Clavero; A Baena; B Lloveras; M Alejo; X León; J García; R Mesía; O Bermejo; T Bonfill; A Aguila; M Guix; R Hijano; M A Pavón; M Torres; S Tous; R Clèries; L Alemany Journal: Sci Rep Date: 2020-08-06 Impact factor: 4.379